We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tenet Healthcare (THC) Stock Slides as Market Rises: Facts to Know Before You Trade
Read MoreHide Full Article
Tenet Healthcare (THC - Free Report) ended the recent trading session at $200.48, demonstrating a -2.12% change from the preceding day's closing price. The stock fell short of the S&P 500, which registered a gain of 0.58% for the day.
Shares of the hospital operator have appreciated by 4.3% over the course of the past month, outperforming the Medical sector's gain of 2.74%, and the S&P 500's gain of 3.68%.
The investment community will be paying close attention to the earnings performance of Tenet Healthcare in its upcoming release. The company is slated to reveal its earnings on October 28, 2025. In that report, analysts expect Tenet Healthcare to post earnings of $3.35 per share. This would mark year-over-year growth of 14.33%. Our most recent consensus estimate is calling for quarterly revenue of $5.25 billion, up 2.42% from the year-ago period.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $15.85 per share and a revenue of $21.15 billion, representing changes of +33.42% and +2.36%, respectively, from the prior year.
Investors might also notice recent changes to analyst estimates for Tenet Healthcare. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, there's been a 0.01% fall in the Zacks Consensus EPS estimate. At present, Tenet Healthcare boasts a Zacks Rank of #4 (Sell).
In terms of valuation, Tenet Healthcare is presently being traded at a Forward P/E ratio of 12.93. This denotes a premium relative to the industry average Forward P/E of 11.86.
Investors should also note that THC has a PEG ratio of 0.88 right now. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The Medical - Hospital industry currently had an average PEG ratio of 1.13 as of yesterday's close.
The Medical - Hospital industry is part of the Medical sector. With its current Zacks Industry Rank of 204, this industry ranks in the bottom 18% of all industries, numbering over 250.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Tenet Healthcare (THC) Stock Slides as Market Rises: Facts to Know Before You Trade
Tenet Healthcare (THC - Free Report) ended the recent trading session at $200.48, demonstrating a -2.12% change from the preceding day's closing price. The stock fell short of the S&P 500, which registered a gain of 0.58% for the day.
Shares of the hospital operator have appreciated by 4.3% over the course of the past month, outperforming the Medical sector's gain of 2.74%, and the S&P 500's gain of 3.68%.
The investment community will be paying close attention to the earnings performance of Tenet Healthcare in its upcoming release. The company is slated to reveal its earnings on October 28, 2025. In that report, analysts expect Tenet Healthcare to post earnings of $3.35 per share. This would mark year-over-year growth of 14.33%. Our most recent consensus estimate is calling for quarterly revenue of $5.25 billion, up 2.42% from the year-ago period.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $15.85 per share and a revenue of $21.15 billion, representing changes of +33.42% and +2.36%, respectively, from the prior year.
Investors might also notice recent changes to analyst estimates for Tenet Healthcare. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, there's been a 0.01% fall in the Zacks Consensus EPS estimate. At present, Tenet Healthcare boasts a Zacks Rank of #4 (Sell).
In terms of valuation, Tenet Healthcare is presently being traded at a Forward P/E ratio of 12.93. This denotes a premium relative to the industry average Forward P/E of 11.86.
Investors should also note that THC has a PEG ratio of 0.88 right now. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The Medical - Hospital industry currently had an average PEG ratio of 1.13 as of yesterday's close.
The Medical - Hospital industry is part of the Medical sector. With its current Zacks Industry Rank of 204, this industry ranks in the bottom 18% of all industries, numbering over 250.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.